跳至主要内容
临床试验/NCT05112341
NCT05112341Unknown不适用

Adjuvant Whole Breast Irradiation in Five Fractions Versus Fifteen Fractions in Early Breast Cancer

Sohag University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2021年6月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
1-disease free survival

研究概览

简要总结

the study aiming for compairing results of hypofractionaton radiotherapy treatment in patient with early breast cancer between two arms the first arm recieving five fractions and the other arm recieving fifteen fraction

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age group ( 18-80) years
  • breast conservation surgery
  • Stages (pT1-3, pN0-1, M0) breast cancer.
  • Any histological type of invasive breast cancer.
  • All grades of breast cancer (I,II,III)

排除标准

  • Stage (III or IV) breast cancer.
  • Metastatic breast cancer (MBC)
  • Recurrent breast cancer.
  • Patients' co-morbidities that contraindicate radiotherapy

结局指标

主要结局

1-disease free survival

时间窗: 2 years

the time free from disease

3- toxicity from treatment

时间窗: 2 years

side effects from treatment

2- overall survival

时间窗: 2 years

the period time from treatment till death

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Heba Ali Elsagheer

assistant lecturer of oncolgy. sohag university hospital

Sohag University

研究点 (1)

Loading locations...

相似试验